Skip to content
Trial Eligibility
Menu

Phenotyping Genetic Risk for Type 2 Diabetes

NCT04024631

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This study tests the hypothesis that non-diabetic individuals with a high genetic risk score for type 2 diabetes have impaired glucose tolerance and insulin resistance compared to those with a low genetic risk score for type 2 diabetes.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Diabetes Mellitus, Type 2
  • Genetics

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
10 to 70 years
Sex
All
Healthy volunteers
Accepted
Sponsor
University of Pennsylvania
Last updated on ClinicalTrials.gov
September 21, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Pennsylvania · 1

  • University of Pennsylvania · Philadelphia, PA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.